FDA Inspection 1082991 — Oxford Biomedica (UK) Limited
The FDA completed an inspection of Oxford Biomedica (UK) Limited on Feb 20, 2019 in Oxford. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 20, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Oxford (United Kingdom)